SEC Tracker
Get the app

Pacira BioSciences PCRX

Viatris to Acquire Pacira for $36.50 per Share

SC TO-C filing

Form
Schedule TO-C
Filed
Importance
Routine
  1. $36.50 per share cash offer
  2. Aggregate equity value of $1.65 billion
  3. Tender offer open for 10 business days
  4. Merger to be completed under Delaware law

Written from the Schedule TO-C on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  3. Geron GERN public float $861M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025